Article Information
vol. 59 no. 5
PubMed
Published By
Print ISSN
Online ISSN
History
- Received February 20, 2022
- Accepted April 6, 2022
- Published online May 19, 2022.
Copyright & Usage
Copyright ©The authors 2022. This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
Author Information
- Lorenzo Guglielmetti1,2,3⇑,
- Gunar Günther4,5,
- Claude Leu4,
- Daniela Cirillo6,
- Raquel Duarte7,8,9,10,
- Alberto L. Garcia-Basteiro11,12,
- Delia Goletti13,
- Mateja Jankovic14,
- Liga Kuksa15,16,
- Florian P. Maurer17,18,19,
- Frédéric Méchaï20,
- Simon Tiberi21,22,
- Frank van Leth23,24,
- Nicolas Veziris2,25,26 and
- Christoph Lange19,27,28,29
- on behalf of the Study Group on Mycobacteria of the European Society of Microbiology and Infectious Diseases (ESGMYC), European Society of Mycobacteriology (ESM), European Respiratory Society (ERS) and
- the Tuberculosis Network European Trials group (TBnet)
- 1Sorbonne Université, INSERM, U1135, Centre d'Immunologie et des Maladies Infectieuses, Cimi-Paris, Paris, France
- 2APHP, Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié-Salpêtrière, Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux, Paris, France
- 3APHP, Infectious Disease Unit, Avicenne Hospital, Bobigny, France
- 4Department of Pulmonology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
- 5Department of Internal Medicine, School of Medicine, University of Namibia, Windhoek, Namibia
- 6WHO Collaborating Centre and TB Supranational Reference Laboratory, San Raffaele Scientific Institute, Milano, Italy
- 7Epidemiology Research Unit (EpiUnit), Institute of Public Health, University of Porto, Porto, Portugal
- 8Departamento de Ciências de Saúde Pública, Ciências Forenses e Educação Médica, Faculty of Medicine, University of Porto, Porto, Portugal
- 9Serviço de Pneumologia, Centro Hospitalar de Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal
- 10National Tuberculosis Program, Directorate-General of Health, Lisbon, Portugal
- 11Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Moçambique
- 12ISGlobal, Hospital Clínic – Universitat de Barcelona, Barcelona, Spain
- 13National Institute for Infectious Diseases L. Spallanzani-IRCCS, Rome, Italy
- 14Clinic for Lung Diseases, University of Zagreb School of Medicine and University Hospital Center Zagreb, Zagreb, Croatia
- 15Riga East University Hospital, TB and Lung Disease Centre, Riga, Latvia
- 16Riga Stradins University, Riga, Latvia
- 17National and Supranational Reference Center for Mycobacteria, Research Center Borstel, Borstel, Germany
- 18Institute of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
- 19German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Borstel, Germany
- 20APHP, Infectious Disease Unit, Avicenne Hospital, Université Paris 13, IAME, INSERM, Bobigny, France
- 21Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University, London, UK
- 22Royal London Hospital, Barts Health National Health Service Trust, London, UK
- 23VU University, Department of Health Sciences, Amsterdam, The Netherlands
- 24Amsterdam Public Health Research Institute, Amsterdam, The Netherlands
- 25APHP, Groupe Hospitalier Universitaire Sorbonne Université, site Saint-Antoine, Département de bactériologie, Paris, France
- 26Sorbonne Université, INSERM, U1135, Centre d'Immunologie et des Maladies Infectieuses, Cimi-Paris, équipe 13, Paris, France
- 27Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany
- 28Respiratory Medicine and International Health, University of Lübeck, Lübeck, Germany
- 29Baylor College of Medicine and Texas Childreńs Hospital, Global TB Program, Houston, TX, USA
- Lorenzo Guglielmetti (lorenzo.guglielmetti{at}aphp.fr)
Funding
Deutsches Zentrum für Infektionsforschung
Article usage
Altmetrics
Vol 59 Issue 5
Table of Contents
Rifapentine access in Europe: growing concerns over key tuberculosis treatment component
